FdaApplication
ANDA 040263
Identifiers
- fda_app_no: ANDA040263
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 1999-02-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 50MG BASE/2ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION |
| METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 250MG BASE/10ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION |
2 products